These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34219917)

  • 21. Fiscal tensions and risk premium.
    Ciżkowicz P; Parosa G; Rzońca A
    Empirica (Dordr); 2022; 49(3):833-896. PubMed ID: 35506056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best practice in communicating the results of European research to the public.
    Ashwell M; Claessens M
    Adv Exp Med Biol; 2005; 569():60-3. PubMed ID: 16137108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance.
    Permanand G; Mossialos E; McKee M
    Clin Med (Lond); 2006; 6(1):87-90. PubMed ID: 16521363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The EU's Precarious Old Normal and the Need for Reform].
    Gabrisch H
    Wirtschaftsdienst; 2021; 101(10):814-820. PubMed ID: 34720234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring the Efficiency of Fiscal Policies for Environmental Pollution Control and the Spatial Effect of Fiscal Decentralization in China.
    Zhou C; Zhang X
    Int J Environ Res Public Health; 2020 Dec; 17(23):. PubMed ID: 33276591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of FDI on the Efficiency of Government Expenditure on Environmental Protection Under Fiscal Decentralization: A Spatial Econometric Analysis for China.
    Zhang J; Qu Y; Zhang Y; Li X; Miao X
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31336960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A critical assessment of the European Commission's proposals for the risk assessment and registration of chemical substances in the European Union.
    Combes R; Dandrea J; Balls M
    Altern Lab Anim; 2003; 31(3):353-64. PubMed ID: 15612876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to Ensure Fiscal Sustainability in Russia.
    Sokolov IA; Belev SG; Suchkova OV
    Stud Russ Econ Dev; 2021; 32(4):383-390. PubMed ID: 34366648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution of European economic institutions during the COVID-19 crisis.
    Camous A; Claeys G
    Eur Policy Anal; 2020 Dec; 6(2):328-341. PubMed ID: 34616911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Information Theory and an Entropic Approach to an Analysis of Fiscal Inequality.
    Vo DH
    Entropy (Basel); 2019 Jun; 21(7):. PubMed ID: 33267357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inherent Instability: The Role of the Output Gap in the Stability and Growth Pact].
    Bender CM; Heise A
    Wirtschaftsdienst; 2021; 101(3):213-220. PubMed ID: 33746306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addressing multimorbidity to improve healthcare and economic sustainability.
    Colombo F; García-Goñi M; Schwierz C
    J Comorb; 2016; 6(1):21-27. PubMed ID: 29090168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer registration, public health and the reform of the European data protection framework: Abandoning or improving European public health research?
    Andersen MR; Storm HH;
    Eur J Cancer; 2015 Jun; 51(9):1028-38. PubMed ID: 24120502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inter-provincial inequality of public health services in China: the perspective of local officials' behavior.
    Chen T; Wang Y; Luo X; Rao Y; Hua L
    Int J Equity Health; 2018 Jul; 17(1):108. PubMed ID: 30064429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supporting health systems in Europe: added value of EU actions?
    Clemens T; Michelsen K; Brand H
    Health Econ Policy Law; 2014 Jan; 9(1):49-69. PubMed ID: 23968231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public debt sustainability in sub-national level: a case of Karnataka.
    Ramu MRA
    Indian Econ Rev; 2021; 56(2):463-485. PubMed ID: 34075258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What drives public health care expenditure growth? Evidence from Swiss cantons, 1970-2012.
    Braendle T; Colombier C
    Health Policy; 2016 Sep; 120(9):1051-60. PubMed ID: 27496155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research on the competitive effect of local government's environmental expenditure in China.
    Pan X; Li M; Guo S; Pu C
    Sci Total Environ; 2020 May; 718():137238. PubMed ID: 32086088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prospects for the European Union's Budgetary Policy].
    Überblick
    Wirtschaftsdienst; 2021; 101(2):77. PubMed ID: 33642643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.